Important Update
Takeda has discontinued global manufacturing of NATPARA® (parathyroid hormone) for Injection as previously announced and will close the associated U.S. Special Use Program. As a result, this website will soon be decommissioned.
TAKEDA WILL CEASE SHIPMENTS OF NATPARA BY DECEMBER 31, 2025 AND NATPARA WILL NO LONGER BE AVAILABLE TO SUP PATIENTS. We understand the impact this may have and encourage you to contact your healthcare team to discuss alternate treatment plans.
Continue